Treatment ofStaphylococcus aureusinfections: new issues, emerging therapies and future directions
- 14 March 2007
- journal article
- review article
- Published by Informa Healthcare in Emerging Drugs
- Vol. 12 (1), 1-22
- https://doi.org/10.1517/14728214.12.1.1
Abstract
Infections due to Staphylococcus aureus are a major cause of morbidity and mortality worldwide. Antimicrobial resistance in strains of S. aureus is a continually evolving problem, including widespread methicillin resistance in hospitals, increasing methicillin resistance in community strains, and the recent acquisition of glycopeptide resistance. New antimicrobials with activity against S. aureus have recently entered the market or are in the late stages of development. In addition, there has been significant interest in the development of novel and immune-based strategies for prevention or treatment of S. aureus infections. This review describes established and emerging therapies for S. aureus infections, and considers the safety profiles and likely impact on present treatment standards of novel agents either undergoing clinical development or emerging onto the market.Keywords
This publication has 101 references indexed in Scilit:
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- The Treatment Triangle for Staphylococcal InfectionsNew England Journal of Medicine, 2006
- Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative StaphylococciClinical Infectious Diseases, 2006
- The Crisis of Resistance: Identifying Drug Exposures to Suppress Amplification of Resistant Mutant SubpopulationsClinical Infectious Diseases, 2006
- Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin–rifampicin combination therapy in an intensive care unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Staphylococcus aureus infective endocarditis: diagnosis and management guidelinesInternal Medicine Journal, 2005
- Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive BacteriaClinical Infectious Diseases, 2005
- Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremiaDiagnostic Microbiology and Infectious Disease, 2005
- Antimicrobial peptides of multicellular organismsNature, 2002